RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

United States ( XML Feed )

Oct 14, 2016 9:59 AM ET

Archived: BUYINS.NET: REM, MDSO, SCHA, REZ, CNI, ULTA Are Seasonally Ripe To Go Up In the Next Five Weeks

Disclosure NewswireTM

iCrowdNewswire - Oct 14, 2016

October 14, 2016 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of iShares FTSE NAREIT Mortgage REITs Index Fund (NYSE:REM), Medidata Solutions Inc. (NASDAQ:MDSO), Schwab U.S. Small-Cap ETF (NYSE:SCHA), iShares FTSE NAREIT Residential Index Fund (NYSE:REZ), Canadian National Railway Company (NYSE:CNI), Ulta Salon Cosmetics & Fragrance Inc. (NASDAQ:ULTA) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

The following stocks are expected to go Up:

Symbol Company Expected Return Odds By The Following Date
REM iShares FTSE NAREIT Mortgage REITs Index Fund 0.91% 88.89% (8 of 9) Monday, October 17th 2016
MDSO Medidata Solutions Inc. 10.68% 85.71% (6 of 7) Monday, November 21st 2016
SCHA Schwab U.S. Small-Cap ETF 5.02% 66.67% (4 of 6) Monday, November 28th 2016
REZ iShares FTSE NAREIT Residential Index Fund 1.60% 88.89% (8 of 9) Monday, October 17th 2016
CNI Canadian National Railway Company 8.16% 78.95% (15 of 19) Monday, November 7th 2016
ULTA Ulta Salon Cosmetics & Fragrance Inc. 1.73% 87.50% (7 of 8) Monday, October 17th 2016

iShares FTSE NAREIT Mortgage REITs Index Fund (NYSE:REM) – REMINGTON OIL & G.

Medidata Solutions Inc. (NASDAQ:MDSO) – Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. The company offers applications and data analytics for clinical development. It offers Medidata Clinical Cloud that provides a software-as-a-service platform of technology and data analytics solutions to optimize activities across clinical development. The company s platform includes Planning Cloud that provides capabilities for study design and planning; and Medidata Rave, an electronic data capture and management system solution. Its platform solutions also include Patient Cloud for direct capture of the voice of the patient in clinical trials; Medidata’s mobile health that offer various ways for customers to utilize the measurements in the scientific, regulatory, and technology environment of clinical trials; Medidata Patient Cloud ePRO, an application for use on various app-ready iOS or Android device; and Study Management Cloud that enable clinical teams to manage, monitor, control, integrate, and report operational and clinical data from patients and sites. Further, the company s platform solutions include a set of risk-based monitoring tools and services that enable customers to assess data quality with risk-based strategies; Payments Cloud solution that automates the task of tracking and calculating payments to individual sites across clinical trials; and Data and Analytics Cloud to surface a range of embedded operational data across the clinical process. Additionally, it offers professional services. The company markets and sells its cloud-based solutions through a direct sales force, as well as through relationships with contract research organizations (CROs) and other strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and academic institutions, CROs, and other entities engaged in clinical trials. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York..


iShares FTSE NAREIT Residential Index Fund (NYSE:REZ) – iShares Trust.

Canadian National Railway Company (NYSE:CNI) – Canadian National Railway Company engages in rail and related transportation business. The company transports cargo serving exporters, importers, retailers, farmers, and manufacturers. It operates a network of approximately 20,000 route miles of track spans Canada and mid-America connecting the Atlantic, the Pacific, and the Gulf of Mexico. The company serves the cities and ports of Vancouver, Prince Rupert (British Columbia), Montreal, Halifax, New Orleans, and Mobile (Alabama), as well as the metropolitan areas of Toronto, Edmonton, Winnipeg, Calgary, Chicago, Memphis, Detroit, Duluth (Minnesota)/Superior (Wisconsin), and Jackson (Mississippi) with connections to various points in North America. Canadian National Railway Company was founded in 1919 and is headquartered in Montreal, Canada..

Ulta Salon Cosmetics & Fragrance Inc. (NASDAQ:ULTA) – Ulta Salon, Cosmetics & Fragrance, Inc. operates as a specialty retailer in the United States. Its stores provide cosmetics, fragrance, haircare, skincare, bath and body products, and salon styling tools. The company also offers cosmetics, which includes products for the face, eyes, cheeks, lips, nails, and brushes; haircare products, such as shampoos, conditioners, styling products, and hair accessories and brushes; and salon styling tools comprising hair dryers, curling irons, and flat irons. In addition, it provides skincare, and bath and body products consisting of products for face, hands, and body; fragrances; nail polish and nail care products; and men s skincare, haircare, and fragrance products. Further, the company offers private label products consisting of Ulta branded cosmetics, skincare, bath and body products, and haircare products; and other health and beauty products. As of January 30, 2016, it operated 874 retail stores in 48 states. The company s full-service salon offers hair, skin, and brow services; and provides products through its Website, ulta.com. Ulta Salon, Cosmetics & Fragrance, Inc. was founded in 1990 and is based in Bolingbrook, Illinois..


BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:


Friction Factor – Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new “Fair Market Making Requirements”
Naked Shorts (RegSho) – Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO


Earnings – Predicts probability, price move and length of move before and after all US stock earnings reports
Seasonality – Predicts probability, price move and length of move based on exact time of year for all US stocks
Group Correlation – Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups
SqueezeTrigger – Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Valuation – Tracks all known valuation models and applies them.
GATS – Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies.
PatternScan – Automates tracking of every technical pattern and predicts next move in stocks.
Insider – Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders
Events – Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641


BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.


Tom Ronk, CEO

Contact Information:

Tom Ronk, CEO

View Related News >